Browne IM, McLaughlin RA, Weadick CS, O'Sullivan S, et al. Irish national real-world analysis of the clinical and economic impact of 21-gene oncotype DX(R) testing in early-stage, 1-3 lymph node-positive, oestrogen receptor-positive, HER2-negative, breast cancer. Breast Cancer Res Treat 2024 Oct 4. doi: 10.1007/s10549-024-07486.
PMID: 39365509